Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Devine

Showing results (471-480 of 577) with videos related to

Pageof 58
Sort By:
British Journal of Haematology|May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylationKristie A Blum, Zhongfa Liu, David M Lucas, et al.
Blood|April 30, 2011
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood graftsClaudio G Brunstein, Ephraim J Fuchs, Shelly L Carter, et al.
Science (New York, N.Y.)|September 7, 2002
Identification of a DNA nonhomologous end-joining complex in bacteriaGeoffrey R Weller, Boris Kysela, Rajat Roy, et al.
Leukemia & Lymphoma|December 1, 2012
Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myelomaNeil C Dunavin, Lai Wei, Patrick Elder, et al.
Neuron|April 17, 2026
Risk reshapes amygdala representation of choicePatrick T Piantadosi, Kendall M Coden, Hyesun Choi, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
Risk reshapes amygdala representation of choicePatrick T Piantadosi, Kendall M Coden, Hyesun Choi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2017
Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR BindingParvathi Ranganathan, Apollinaire Ngankeu, Nina C Zitzer, et al.
Biomedical Materials (Bristol, England)|July 30, 2021
Nanocellulose for peripheral nerve regeneration in rabbits using citric acid as crosslinker with chitosan and freeze/thawed PVAGabriel G de Lima, Emílio L de S Júnior, Bruno B Aggio, et al.
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Pageof 58

Showing results (471-480 of 577) with videos related to

Sort By:
Pageof 58
British Journal of Haematology|May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylationKristie A Blum, Zhongfa Liu, David M Lucas, et al.
Blood|April 30, 2011
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood graftsClaudio G Brunstein, Ephraim J Fuchs, Shelly L Carter, et al.
Science (New York, N.Y.)|September 7, 2002
Identification of a DNA nonhomologous end-joining complex in bacteriaGeoffrey R Weller, Boris Kysela, Rajat Roy, et al.
Leukemia & Lymphoma|December 1, 2012
Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myelomaNeil C Dunavin, Lai Wei, Patrick Elder, et al.
Neuron|April 17, 2026
Risk reshapes amygdala representation of choicePatrick T Piantadosi, Kendall M Coden, Hyesun Choi, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
Risk reshapes amygdala representation of choicePatrick T Piantadosi, Kendall M Coden, Hyesun Choi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2017
Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR BindingParvathi Ranganathan, Apollinaire Ngankeu, Nina C Zitzer, et al.
Biomedical Materials (Bristol, England)|July 30, 2021
Nanocellulose for peripheral nerve regeneration in rabbits using citric acid as crosslinker with chitosan and freeze/thawed PVAGabriel G de Lima, Emílio L de S Júnior, Bruno B Aggio, et al.
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Pageof 58